Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiangkiat Tan

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Managed Care|July 11, 2012
Impact of positive airway pressure among obstructive sleep apnea patientsQian Cai, Hiangkiat Tan, Joseph Singer
Drug Safety|June 1, 2005
Designing safe drug namesBruce L Lambert, Swu-Jane Lin, Hiangkiat Tan
International Journal of Chronic Obstructive Pulmonary Disease|April 17, 2013
Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysisAzza Abudagga, Shawn X Sun, Hiangkiat Tan, et al.
The American Journal of Managed Care|July 19, 2018
Cost of biologic treatment persistence or switching in rheumatoid arthritisTao Gu, Alex Mutebi, Bradley S Stolshek, et al.
Managed Care (Langhorne, Pa.)|September 25, 2015
Roflumilast: Who Is Using It and How It Affects Health Care Resource Utilization and CostsRahul Jain, Qian Cai, Shawn X Sun, et al.
American Health & Drug Benefits|May 26, 2015
Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivololStephanie Chen, An-Chen Fu, Rahul Jain, et al.
Pharmacoepidemiology and Drug Safety|September 2, 2005
Frequency estimates from prescription drug datasets (revision of #04-11-066A)Swu-Jane Lin, Bruce Lambert, Hiangkiat Tan, et al.
Current Medical Research and Opinion|October 7, 2022
Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemiaLori A Leslie, Nilesh Gangan, Hiangkiat Tan, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular AtrophyHiangkiat Tan, Tao Gu, Er Chen, et al.
Clinical Therapeutics|May 28, 2018
Understanding the Patient's Journey in the Diagnosis and Treatment of Multiple Sclerosis in Clinical PracticeJay Visaria, Nina Thomas, Tao Gu, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Managed Care|July 11, 2012
Impact of positive airway pressure among obstructive sleep apnea patientsQian Cai, Hiangkiat Tan, Joseph Singer
Drug Safety|June 1, 2005
Designing safe drug namesBruce L Lambert, Swu-Jane Lin, Hiangkiat Tan
International Journal of Chronic Obstructive Pulmonary Disease|April 17, 2013
Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysisAzza Abudagga, Shawn X Sun, Hiangkiat Tan, et al.
The American Journal of Managed Care|July 19, 2018
Cost of biologic treatment persistence or switching in rheumatoid arthritisTao Gu, Alex Mutebi, Bradley S Stolshek, et al.
Managed Care (Langhorne, Pa.)|September 25, 2015
Roflumilast: Who Is Using It and How It Affects Health Care Resource Utilization and CostsRahul Jain, Qian Cai, Shawn X Sun, et al.
American Health & Drug Benefits|May 26, 2015
Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivololStephanie Chen, An-Chen Fu, Rahul Jain, et al.
Pharmacoepidemiology and Drug Safety|September 2, 2005
Frequency estimates from prescription drug datasets (revision of #04-11-066A)Swu-Jane Lin, Bruce Lambert, Hiangkiat Tan, et al.
Current Medical Research and Opinion|October 7, 2022
Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemiaLori A Leslie, Nilesh Gangan, Hiangkiat Tan, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Healthcare Utilization, Costs of Care, and Mortality Among Patients With Spinal Muscular AtrophyHiangkiat Tan, Tao Gu, Er Chen, et al.
Clinical Therapeutics|May 28, 2018
Understanding the Patient's Journey in the Diagnosis and Treatment of Multiple Sclerosis in Clinical PracticeJay Visaria, Nina Thomas, Tao Gu, et al.
Pageof 5